Skip to search formSkip to main contentSkip to account menu

Integrilin

Known as: Integrelin 
National Institutes of Health

Related topics

Related topics

2 relations
100 ML eptifibatide 0.75 MG/ML Injection [Integrilin]

Broader (1)

eptifibatide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Equipoise in the Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT): a critical appraisal
Enhanced Supression of the Platelet IIb/IIIa Receptor with Integrilin Trial (ESPRIT) was a multicenter randomized controlled… 
Highly Cited
2003
Highly Cited
2003
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction…
2002
2002
Safety and Efficacy of Combined Use of Low Molecular Weight Heparin (Enoxaparin, Lovenox) and Glycoprotein IIb/IIIa Receptor Antagonist (Eptifibatide, Integrelin) During Nonemergent Coronary and…
Coronary and peripheral intervention requires intraprocedural anticoagulation to prevent intraluminal thrombosis. Traditionally… 
2001
2001
Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists.
2001
2001
Attenuation of Rebound Ischemia After Discontinuation of Heparin Therapy by Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Acute Coronary Syndromes: Observations From the…
Background—A reactivation of ischemia after the discontinuation of intravenous heparin in acute coronary syndromes has been… 
Review
1996
Review
1996
Survey of current practice patterns for percutaneous transluminal coronary angioplasty. SANDBAG Nursing Coordinators.
BACKGROUND The increasing complexity of coronary intervention has led to variations in current patterns of nursing practice for… 
1996
1996
Integrelin for emergency coronary artery stenting
1996
1996
Refining the treatment of women with unstable angina—A randomized, double‐blind, comparative safety and efficacy evaluation of integrelin™ versus aspirin in the management of unstable angina
Background: Although women typically develop coronary artery disease several years after men, once they have symptomatic disease… 
Review
1995
Review
1995
Enhancing safety and outcomes with the newer antithrombotic and antiplatelet agents.
1994
1994
Fibrinogen receptor antagonists
Fibrinogen receptor antagonists represent a potential new form of antithrombotic therapy for the treatment or prevention of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)